JETEMA, Co., Ltd.

KOSDAQ 216080.KQ

JETEMA, Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 2.53

JETEMA, Co., Ltd. Revenue Per Share is USD 2.53 for the year ending December 31, 2023, a 23.84% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • JETEMA, Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 2.04, a 29.78% change year over year.
  • JETEMA, Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 1.57, a 43.04% change year over year.
  • JETEMA, Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 1.10, a 55.79% change year over year.
  • JETEMA, Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.71, a 20.47% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
KOSDAQ: 216080.KQ

JETEMA, Co., Ltd.

CEO Jeong Sun Nam
IPO Date Nov. 14, 2019
Location South Korea
Headquarters 1283-4, Gagok-ri
Employees 227
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers botulinum toxins, fillers, anti-aging solutions, lifting threads for medical treatment, laser surgical instruments, and skin care hyaluronic acid masks. The company is headquartered in Wonju, South Korea.

StockViz Staff

January 15, 2025

Any question? Send us an email